STJ » Topics » FORM 8-K

This excerpt taken from the STJ 8-K filed Oct 26, 2009.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Oct 23, 2009.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Oct 21, 2009.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Jul 22, 2009.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Apr 22, 2009.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Jan 27, 2009.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Jan 7, 2009.

FORM 8-K



CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 31, 2008

 


This excerpt taken from the STJ 8-K filed Dec 19, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 18, 2008

 


This excerpt taken from the STJ 8-K filed Dec 1, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 1, 2008

 


This excerpt taken from the STJ 8-K filed Nov 26, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 21, 2008

 


This excerpt taken from the STJ 8-K filed Oct 15, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Jul 16, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Jul 7, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed May 5, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Apr 16, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Feb 25, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 25, 2008

 


This excerpt taken from the STJ 8-K filed Jan 23, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Jan 8, 2008.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 8, 2008

 


 

This excerpt taken from the STJ 8-K filed Dec 10, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Oct 18, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Oct 9, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 8, 2007

 


This excerpt taken from the STJ 8-K filed Jul 18, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

This excerpt taken from the STJ 8-K filed Jul 2, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 26, 2007

 


This excerpt taken from the STJ 8-K filed May 18, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 16, 2007

 


This excerpt taken from the STJ 8-K filed May 7, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 2, 2007

 


This excerpt taken from the STJ 8-K filed Apr 25, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 19, 2007

 


This excerpt taken from the STJ 8-K filed Apr 20, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 19, 2007

 


This excerpt taken from the STJ 8-K filed Apr 19, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 19, 2007

 


This excerpt taken from the STJ 8-K filed Apr 19, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 19, 2007

 


This excerpt taken from the STJ 8-K filed Mar 1, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 27, 2007

 


This excerpt taken from the STJ 8-K filed Jan 31, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 25, 2007

 


This excerpt taken from the STJ 8-K filed Jan 29, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 29, 2007

 


This excerpt taken from the STJ 8-K filed Jan 25, 2007.

FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 25, 2007

 


This excerpt taken from the STJ 8-K filed Dec 18, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 13, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 



This excerpt taken from the STJ 8-K filed Oct 18, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 18, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 


 




Item 2.02.

Results of Operations and Financial Condition.

 

On October 18, 2006, St. Jude Medical, Inc. issued a press release concerning its financial results for the third quarter of 2006. A copy of the press release is furnished as Exhibit 99.1 to this report.

 

 

 

 

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)  Exhibits:

 

 

99.1

Press release issued by St. Jude Medical, Inc. on October 18, 2006.














 




This excerpt taken from the STJ 8-K filed Sep 13, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 12, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 


 




This excerpt taken from the STJ 8-K filed Aug 31, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 27, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



Item 2.05  

Costs Associated with Exit or Disposal Activities

On August 27, 2006, management of St. Jude Medical, Inc. (the “Company”) committed the Company to combining its Cardiac Surgery and Cardiology divisions to create a new Cardiovascular Division, effective January 1, 2007, and to streamlining the Company’s sales and customer service operations in certain international geographies. The decision to combine the two divisions and to make the changes in its international operations was based on management’s expectation that the combination and other changes would increase operating efficiencies and permit management to use the associated savings to invest in research and development.

 

As a result of the restructuring plan, the Company will record a pre-tax charge in the third quarter of 2006 that management currently estimates to be in the range of $25 million to $35 million. The estimate is comprised of $9 million to $10 million of workforce reduction costs, $7 million to $8 million of inventory write-downs, $6 million to $13 million of fixed asset and other asset write-offs and $3 million to $4 million of other exit costs. The portion of the estimated charges that are expected to result in future cash expenditures is estimated to be $12 million to $14 million. These activities are expected to be completed, and the associated charges are expected to be utilized, by December 31, 2006.

 

Item 7.01  

Regulation FD Disclosure

 

On August 28, 2006, the Company issued a press release concerning the restructuring plan. A copy of the press release is furnished as Exhibit 99.1 to this report.

 

 

Item 9.01  

Financial Statements and Exhibits

 

(d)  Exhibits:

 

99.1

Press release issued by the Company on August 28, 2006.

 




 

This excerpt taken from the STJ 8-K filed Aug 2, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 27, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



This excerpt taken from the STJ 8-K filed Jul 31, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 30, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



This excerpt taken from the STJ 8-K filed Jul 19, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 19, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



This excerpt taken from the STJ 8-K filed Jun 2, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 1, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



This excerpt taken from the STJ 8-K filed May 16, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 10, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



Item 1.01    Entry into a Material Definitive Agreement.

St. Jude Medical, Inc. 2006 Stock Plan

On May 10, 2006, at the 2006 Annual Meeting of Shareholders (the “Annual Meeting”) of St. Jude Medical, Inc. (the “Company”), the Company’s shareholders adopted the St. Jude Medical, Inc. 2006 Stock Plan (the “2006 Stock Plan”), effective as of February 24, 2006.

The purpose of the 2006 Stock Plan is to enable the Company and its subsidiaries to retain and attract executives and other key employees, non-employee directors and consultants who contribute to the Company’s success by their ability, ingenuity and industry, and to enable these individuals to participate in our long-term success and growth by giving them a proprietary interest in the Company. The 2006 Stock Plan, which is administered by the Company’s Compensation Committee, authorizes the grant of stock options and stock appreciation rights to officers and other key employees, directors and consultants of the Company and the Company’s affiliates. An aggregate of 5,000,000 shares of the Company’s common stock is authorized for issuance under the 2006 Stock Plan, subject to adjustments as set forth in the 2006 Stock Plan. In addition, certain awards under the 2006 Stock Plan are subject to limitations, as set forth in the 2006 Stock Plan.

Under the 2006 Stock Plan, each non-employee director who, on or after May 1, 2006 is (1) elected, re-elected or serving an unexpired term as a director of the Company at any annual meeting of shareholders or (2) elected as a director of the Company at any special meeting of shareholders, will, as of the date of such annual or special meeting, automatically be granted a non-qualified stock option to purchase 5,600 shares of the Company’s common stock. Each non-employee director who is appointed as a director of the Company at any time other than at an annual or special meeting of the Company’s shareholders will automatically be granted a non-qualified stock option to purchase a pro rata number of the 5,600 shares of common stock, calculated in accordance with the provisions of the 2006 Stock Plan.

The Board of Directors may amend, alter or discontinue the 2006 Stock Plan at any time. However, shareholder approval must be obtained for certain amendments to the 2006 Stock Plan, as set forth in the 2006 Stock Plan. The 2006 Stock Plan terminates on February 23, 2016.

This summary of the 2006 Stock Plan is qualified in its entirety by reference to the full text of the 2006 Stock Plan, a copy of which is attached as Exhibit 10.1 and incorporated herein by reference. A more detailed summary of the 2006 Stock Plan can be found in the Company’s Proxy Statement for the Annual Meeting filed with the Securities and Exchange Commission on March 30, 2006.

Option Grants to Non-Employee Directors

On May 10, 2006, each of the following non-employee directors of the Company received an automatic grant of a non-qualified stock option to purchase 5,600 shares of the Company’s common stock: John W. Brown, Richard R. Devenuti, Stuart M. Essig, Thomas H. Garrett III, Michael A. Rocca, David A. Thompson, Stefan K. Widensohler and Wendy L. Yarno. Such grants were made pursuant to the 2006 Stock Plan. The form of Non-Qualified Stock Option Agreement for Non-Employee Directors (the “Stock Option Agreement”) used in connection with grants to non-employee directors under the 2006 Stock Plan, including the grants to the directors listed above, is attached hereto as Exhibit 10.2 and is incorporated herein by reference.




Each option granted to the non-employee directors has a term of eight years and is subject to the termination provisions set forth in the Stock Option Agreement. The options become fully exercisable beginning six months after the date the option is granted; provided, however, that from and after a change of control, the options become immediately exercisable in full. Upon termination of a director’s service as a director of the Company, the unvested portion of any stock options then held by such director will not thereafter be exercisable.

This summary of the Stock Option Agreement is qualified in its entirety by reference to the full text of the Stock Option Agreement, a copy of which is attached as Exhibit 10.2 and incorporated herein by reference.

Item 9.01   Financial Statements and Exhibits.

    (d)   Exhibits:

      10.1   St. Jude Medical, Inc. 2006 Stock Plan

      10.2   Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under the St. Jude Medical, Inc. 2006 Stock Plan

This excerpt taken from the STJ 8-K filed Apr 21, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 21, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



This excerpt taken from the STJ 8-K filed Apr 19, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 19, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



This excerpt taken from the STJ 8-K filed Apr 5, 2006.

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 4, 2006


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki